Back to search

Article

An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants

2022-04-19

Abstract excerpt

Respiratory viral infections, especially Influenza (endemic) or SARS-CoV-2 (pandemic since 2020), cause morbidity and mortality worldwide. Despite remarkable progress in the development and deployment of vaccines, they are clearly impacted by the rapid emergence of viral variants. The development of an off-the-shelf, effective, safe, and low-cost drug for prophylaxis against respiratory viral infections is a major...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
783eed86-250f-58d1-b531-3fb3eb49a228
DOI
10.1101/2022.04.18.488695
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variantsDOI 10.1101/2022.04.18.488695
Select a neighboring publication to make it the new centre.